Tablets & Capsules

TC0118

Issue link: https://www.e-digitaleditions.com/i/922724

Contents of this Issue

Navigation

Page 52 of 61

Tablets & Capsules January 2018 43 people news Yogesh D. Sadhale was appointed associate director of pharmaceutical development at Metrics Contract Services, a unit of Mayne Pharma, Greenville, NC, that provides con- tract pharmaceutical development and manufacturing. He previously served as manager of pharmaceutical and process technology at Patheon Manufacturing Services. Gattefossé awarded Andreas Bernkop-Schnürch its North America award for Excellence in Research and Development with Lipid Excipients. The award recognizes Bernkop- Schnürch's work developing peptide and protein drug formulations using lipid-based excipients. He is a profes- sor at the Institute of Pharmacy, University of Innsbruck, Austria. David Rose was appointed manag- ing director at Spiroflow Automation Solutions. He was a vice president and manager at Precision Castparts in Charlotte, NC. Adents, East Windsor, NJ, hired Pavel Lotkov as director of product development. Adents provides serial- ization and track-and-trace systems. Lotkov managed Eli Lilly's global serialization program. H o v i o n e , L i s b o n , P o r t u g a l , appointed Frédéric Kahn as vice president of marketing and sales. Kahn was most recently with Lonza, where he managed key accounts. advertiser index B Biocaps Enterprises 15 C Caps Canada 8 Capsugel 5 D Donaldson Torit 19 F Fette Compacting America 3 J Jost Chemical 33 K Kikusui USA 1 Kraemer US 29 M Material Flow Solutions 14 Molded Fiber Glass Tray 13 N Natoli Engineering Cover 4 Q Qualicaps 7, 27 S Sotax 10 Suheung Capsule 25 T Techceuticals 13 Torpac 15 Tri-Mer 16 Tri-Star Technologies C2 V Vac-U-Max 9 Spotlight on nutraceuticals A AlfaCaps 32G B Best Formulations 32E R Ribus 32F S Soft Gel Technologies 32D der-in-capsule and powder-in-bottle forms, which eliminate the need for excipient compatibility and stability studies for Phase 1 clinical evalua- tions, allows rapid screening of APIs, and can reduce early-stage develop- ment time by as much as 45 percent. The company also expanded its high-containment capabilities here, increasing its annual capacity for liq- uid-filled hard capsules by 250. Roquette opens Asia Pacific headquarters SINGAPORE—Roquette opened an Asia Pacific headquarters here. The site includes a 1,100-square-me- ter innovation center, research labs, and offices and provides technical service. Based in France, the com- pany supplies pharmaceutical excipi- ents and food ingredients. W.R. Grace acquires license for silica-based drug delivery COLUMBIA, MD—W.R. Grace, a s p e c i a l t y c h e m i c a l s u p p l i e r , acquired the licensing rights for ordered mesoporous silica-based drug delivery technology from Formac Pharmaceuticals, Leuven, Belgium. The technology, which the two companies developed jointly, enhances the oral bioavailability of poorly soluble APIs. Auburn Systems, FilterSense merge BEVERLY, MA—Auburn Systems, a pioneer in triboelectric particulate flow monitoring based in Danvers, MA, merged with FilterSense, which supplies particulate monitors and fil- tration controls. The new company, Auburn FilterSense, supplies continu- ous particulate monitors and filter leak detectors. All employees, brands, and sales channels will be preserved.

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC0118